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I.

Introduction
To many Americans, sports enthusiasts, and cancer patients, Lance Armstrong’s

confession to Oprah Winfrey on January 17th, 2013 was both shocking and game
changing 1. Many lost their golden boy who had won seven Tours de France, some lost
respect for the sport that had claimed to be clean time and again, and others lost hope that
they too could survive cancer just like Lance and come back stronger than ever 2. Lance’s
confession, however, is game changing on different levels (i.e. anti doping measures,
professional sports' credibility, sponsorship fallout) now that sporting organizations and
anti-doping agencies have been completely embarrassed by the fact that athletes like
Lance have been able to beat their tests for so long 3. In the cycling world alone, even
long-time Dutch sponsor Rabobank (1996-2012) pulled out, leaving its team named
1

Oprah Winfrey, Lance Armstrong Talks to Oprah, OWN (last visited May 14, 2013),
http://www.oprah.com/own_tv/onc/lance-armstrong-one.html.
2
Steve Almasy, Cycling, Facing An Uphill Climb, Hopes Next Hero Just Around Bend,
CNN, (last visited May 14, 2013), http://www.cnn.com/2013/01/18/sport/cyclingfuture/index.html?hpt=hp_c3.
3
David Walsh, UCI Embarrassed by Lance Armstrong Report, RTE NEWS (last visited
May 14, 2013), http://www.rte.ie/news/player/2012/1022/3420156-uci-embarrassed-bylance-armstrong-report-the-sunday-times-chief-sports-writer-david-walsh/.
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"Blanco" for lack of a title sponsor 4. Further, the International Cycling Union (UCI) is
taking extra precautions for this summer's Tour de France by cooperating with two
independent agencies it has bumped heads with in the past; the Cycling Anti-Doping
Foundation (CADF) and the French Anti-Doping Agency (AFLD) 5. Whether the 2013
Tour de France is won clean will remain to be scene, and after cancelling the results from
1999-2005 (the Lance years) its credibility depends on it 6.
While cycling and other sports might go through a period of clean competition as
a reaction to the Armstrong scandal, inevitably athletes seeking a competitive edge will
find new methods of beating the tests. “Gene doping,” or the use of gene therapy
techniques to increase the production of performance-enhancing proteins, might just be
the next big thing 7! Also, given the financial incentives of winning a Tour de France,
World Series, or Superbowl, the athletic field might just be the first place where genetic
modification is implemented. As each new method of enhancing performance is released,
the ever slow-to-catch-up anti-doping controls seem more and more a futile exercise.
Authorities such as the World Anti Doping Agency (WADA) and the U.S. Anti
Doping Agency (USADA) will have to devise a way to regulate the future of gene
doping. How they develop such a method will be interesting to see in coming years since
there is neither a test, nor a human trial authorities can point to as a guinea pig. One such
4

Rabobank Ends Sponsorship of Professional Cycling Team, BBC (last visited May 14,
2013), http://www.bbc.co.uk/sport/0/cycling/20001685.
5
Yuzuru Sunada, UCI and AFLD to Cooperate at Tour, PELOTON (last visited May 14,
2013), http://www.pelotonmagazine.com/Feedzone/content/6/2267/UCI-and-AFLD-toCooperate-at-Tour.
6
Graham Dunbar, Lance Armstrong Stripped of His 7 Tour de France Titles, WLTV (last
visited May 14, 2013), http://www.wwltv.com/sports/UCI-agrees-to-strippingArmstrong-of-Tour-de-France-medals-175217311.html.
7
MICHAEL J. SANDEL, THE CASE AGAINST PERFECTION: ETHICS IN THE AGE OF GENETIC
ENGINEERING 45-62 (Belknap Press, 1st ed. 2009).
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method would be to completely ban gene doping from competition such as performanceenhancing pharmaceutical substances, while another would be to treat it as a permissible
technological innovation such as the prosthetic legs used by the “Blade Runner,” Oscar
Pistorius 8. The mere fact that WADA has already labeled the practice "gene doping" is
indicative of how they intend to treat it. Still, they have jumped the gun and failed to
make an objective decision on a currently experimental procedure.
This paper will explore the world of gene doping and its intersection with law in
athletics. First, I will provide an overview of gene doping before diving into the legal and
moral framework of doping in athletics. Here, I will argue that gene doping does not fit
within the present framework of prohibiting performance-enhancing drugs and
techniques. The very nature of gene doping will require anti-doping agencies to take a
fresh look and take a new approach to regulate gene doping's "gray" areas. Finally, I will
propose that sporting bodies adopt a framework to allow genetically enhanced athletes to
compete side-by-side with natural athletes, or alternatively, in a league of their own so
that some level of fairness and safety is preserved while also letting all athletes compete,
natural or genetically enhanced.

II.

What Exactly is Gene Doping?
The basic premise behind gene doping is introducing a desired gene into the

athlete’s body, which will incorporate into his or her cells and be expressed as a natural

8

"Blade Runner's" Artificial Legs Controversial at Olympics, CBS NEWS (last visited
May 14, 2013), http://www.cbsnews.com/video/watch/?id=7416890n.
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gene 9. For example, if a person wanted to run faster and can pinpoint a number of genes
that can make them do so, that person would incorporate those genes into their genome
and genetically modify him or herself to run faster. Two potential forms of gene doping
are: somatic cell modification in which genes are modified in a bodily cell like a muscle
or lung, and germline modification in which a sperm, egg, or embryo is genetically
modified, meaning the enhancements pass from one generation to another 10. The focus
of this paper is on somatic cell modification since athletes are more likely to gene dope
themselves, though the possibility of parents breeding enhanced athletes certainly exists
11

. There are currently over a thousand gene therapy trials that are looking for ways to

cure diseases, and it is thought that the same techniques employed in these trials would be
used to introduce performance-enhancing genes into the athlete’s body 12. The three
methods that could introduce artificial genes into an athlete’s body are: loading those
genes onto a virus that is introduced into the body, cultured cells that are modified and
introduced into the body, and injecting foreign DNA into the athlete’s muscle or
bloodstream 13. Each method is described more thoroughly below.

9

Susan L. Nasr, How Gene Doping Works, HOW STUFF WORKS (last visited May 14,
2013), http://science.howstuffworks.com/life/genetic/gene-doping.htm.
10
Kathi E. Hanna, Germline Gene Transfer, NATIONAL HUMAN GENOME RESEARCH
INSTITUTE (last visited May 14, 2013), http://www.genome.gov/10004764; Nasr supra
note 9.
11
Susannah Baruch, Human Germline Genetic Modification: Issues and Options for
Policymakers, GENETICS AND PUBLIC POLICY CENTER,
http://www.dnapolicy.org/images/reportpdfs/HumanGermlineGeneticMod.pdf; Hanna
supra note 10.
12
ANGELA J. SCHNEIDER & THEODORE FRIEDMAN, GENE DOPING IN SPORTS: THE SCIENCE
AND ETHICS OF GENETICALLY MODIFIED ATHLETES 30 (Academic Press, 1st ed. 2006).
13
Mehmet Unal & Durisehvar Ozer Unal, Gene Doping in Sports, 34 SPORTS MED. 357,
358 (2004).
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A. Methods of Delivery
Virus Loading: T. Beiter of the University of Tubigen, Department of Sports
Medicine, explained how a virus would first be needed to provide a means of delivering
the genetic material in the body 14. Before infecting the subject, the virus is modified or
loaded with a "cassette" of DNA 15. The virus, once in the body, delivers the cassette of
genetic material into the cells, forming a blueprint of whatever proteins expression is
desired 16. Viruses have the most capacity to carry genetic material, and are thought to be
the preferred method of gene doping 17.
Modified Cells: M.B. Rosenberg of the University of California School of
Medicine, Department of Pediatrics explained how fibroblasts were genetically modified
to secrete nerve growth factor (NGF) by infection with a retro virus before implanting the
fibroblast into mice with surgical lesions 18. The grafted cells were successful and
produced enough NGF to stop degeneration of neurons, which would die if left untreated
19

.

14

Thomas Beiter et al., Establishing A Novel Single-Copy Primer-Internal Intron
Spanning PCR (spiPCR) Procedure For The Direct Detection Of Gene Doping, 14
EXERC IMMUNOL REV. 73-85 (2008).
15

Alexis C. Madrigal, By the Next Olympics, Athletes May Be Getting Routine Gene
Doping Tests, THE ATLANTIC (last visited May 14, 2013),
http://www.theatlantic.com/technology/archive/2012/08/by-the-next-olympics-athletesmay-be-getting-routine-gene-doping-tests/260700/.
16
Id.
17
Christie Aschwaden, Gene Cheats, NEW SCIENTIST (last visited May 14, 2013),
http://www.archway.ac.uk/Activities/Departments/SHHP/downloads/epo/Genecheats/gen
echeats.html.
18
M.B. Rosenberg et al, Grafting Genetically Modified Cells to the Damaged Brain:
Restorative Effects of NGF Expression, SCIENCE,
http://www.sciencemag.org/content/242/4885/1575.full.pdf.
19
Id.
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Foreign DNA Injection: I. Danko of the University of Wisconsin-Madison,
Department of Pediatrics explained his method of injecting foreign DNA in mice, dogs,
and monkeys 20. He injected DNA over a 1-minute period using a 1ml syringe and 27gauge needle 21. He explains that the animals' muscles were directly exposed to facilitate
injection into specific muscle groups and the incisions were later closed 22. The use of
naked DNA plasmids yielded the highest expression two weeks after the procedure 23.
This procedure looks the most similar to pharmaceutical doping, and would likely be the
least popular for its invasiveness.

B. Target Genes and Possibilities
There are several genes with different potential advantages for athletes interested
in gene doping: Erythropoietin (EPO) for endurance, Insulin-like Growth Factor-1 (IGF1) and Myostatin for strength, Vascular Endothelial Growth Factor (VEGF) for increased
blood flow, and Leptin for weight loss 24. Two of these are common in pharmaceutical
doping and would be immensely popular in gene doping: the introduction of EPO in
endurance athletes, and IGF-1 in power athletes 25. The others would likely be
supplementary, used to further enhance the effects of EPO and IGF-1.

20

I. Danko et al, High Expression of Naked Plasmid DNA in Muscles of Young Rodents,
HUMAN MOLECULAR GENETICS, http://hmg.oxfordjournals.org/content/6/9/1435.full.pdf.
21
Id.
22
Id.
23
Id.
24
Unal & Unal, supra note 13, at 358.
25
Edward H. Jurith & Mark W. Beddoes, The United States’ and International Response
to the Problem of Doping in Sports, 12 FORDHAM INTELLECTUAL PROPERTY, MEDIA, &
ENTERTAINMENT L.J. 461, 470 (2002).
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EPO has long been used in sports such as cycling and running because it is a
hormone produced by the kidney that increases the number of red blood cells in the body,
which help the athlete absorb more oxygen and thus, augment his or her aerobic capacity
26

. EPO’s synthetic version, Epoetin Alfa, is commonly used to treat forms of cancer and

kidney diseases, while also used illegally by athletes looking to increase their endurance
in competition 27. Ex vivo EPO gene transfers have already been successfully introduced
into mice, triggering increased red blood cell counts 28. If this method were one day
introduced to humans, the results would be both positive and negative. On the one hand it
would be another, perhaps, more effective method of treating diseases and cancers, while
on the other hand it would be another way for athletes to cheat their competition. For
athletes, EPO gene transfers mean they can stimulate the kidney to produce more
"natural" (now that it has incorporated in the human genome) EPO, which increases red
blood cells, raises hematocrit levels, and permanently boost their performance.
Likewise, IGF-1 has been successfully introduced into mice via in vivo gene
transfers, which increased muscle growth 29. This form of gene transfer would be popular
among baseball, basketball, and football players as it could be injected directly into the
muscles they wish to grow, producing localized results. Through this method, athletes
could target what it is they need to improve, whether it is jumping higher, throwing
26

I. Casoni et al, Hematological Indices of Erythropoietin Administration in Athletes,
INTERNATIONAL JOURNAL OF SPORTS MEDICINE,
https://profile.thieme.de/HTML/sso/ejournals/login.htm?type=default&subsidiary=www.
thieme-connect.com&hook_url=https%3A%2F%2Fwww.thiemeconnect.com%2Fejournals%2Fpdf%2F10.1055%2Fs-2007-1021183.pdf.
27
SCHNEIDER & FRIEDMANN, supra note 12, at 44.
28
Id. at 44-45.
29
Melinda Wenner, How to Be Popular During the Olympics: Be H. Lee Sweeney, Gene
Doping Expert, SCIENTIFIC AMERICAN, (last visited May 14, 2013),
http://www.scientificamerican.com/article.cfm?id=olympics-gene-doping-expert.
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faster, or hitting harder without spending countless hours in the gym. Though IGF-1 is
banned by anti-doping bodies, it is widely available on the Internet in various forms of
"Deer Antler Spray" 30. Several collegiate and professional football players have been
linked to the substance in recent years, spurring cease-and-desist letters to break the line
of communication between manufacturers and athletes 31. The genetic introduction of
IFG-1 into human athletes means they can produce more power and avoid current forms
of detection since the procedure would only need to be done once instead of periodically.
Similarly, proteins such as Myostatin would take the place of clenbuterol, which
has been used to treat asthma as well as help athletes cut fat and increase muscle 32.
Schneider and Friedmann have commented that by adjusting the metabolism of particular
muscles in mice they were able to increase “slow-twitch” muscle fibers via the
peroxisome proliferator-activated receptor (PPAR) delta gene allowing those mice to
increase their endurance by reducing fat and functioning more efficiently 33. What this
means for human athletes is that they can tailor their muscle fibers to better meet the
demands of their sport. The two extremes are endurance (i.e. marathon runner) and power
(i.e. 100 meter sprinter) and modifying one's fast or slow twitch fibers can make one run
longer or sprint faster.

30

Jerry Hinnen, S.W.A.T.S. Salesman Says He Watched Tide Players Use Deer Spray,
CBS SPORTS, (last visited May 14, 2013),
http://www.cbssports.com/collegefootball/blog/eye-on-college-football/21623944/swatssalesman-says-he-watched-tide-players-use-deer-spray.
31
Id.
32
Wenner, supra note 29, at 12.
33
SCHNEIDER & FRIEDMANN, supra note 12, at 46.
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C. Advantages of Gene Doping: Permanence and Lack of Detectability
There are at least two reasons why gene doping would be preferable to
pharmaceutical doping to the athlete seeking an edge. Genetic modification is permanent,
thus, once the foreign genes are introduced into the athlete, they become his or her own
genetic material 34. By making doping a one-shot process, the cheating athlete would
likely save money over the long-term, but more importantly eliminate the chance of
getting caught by not having to periodically reintroduce a pharmaceutical drug 35. Just
think how much more discrete a doper would be if every time he raised his arms in
victory at the finish line or the podium, there would be no signs of needle injections on
his arms (See
https://securecdn.disqus.com/uploads/mediaembed/images/437/1408/original.jpg).
Similar to the reason above, gene doping is virtually undetectable because
engineered genes produce proteins that look identical to naturally-occurring ones 36.
Further, certain gene doping methods would not be detectable by blood tests, as they
would be entirely contained in the muscle and not circulate in the blood at all 37.
Extremely invasive muscle biopsies would be the only means of detection, however, few
athletes would submit to slicing their muscles for such a test 38. Though tests are
developing, there are no official gene doping tests as of now, making the practice
invisible.

34

Kristen Jo Custer, From Mice to Men: Genetic Doping in International Sports. 30
HASTINGS INTERNATIONAL & COMPARATIVE L. REV. 181, 188 (2007).
35
Id.
36
Aschwaden, supra note 17.
37
Wenner, supra note 29, at 13.
38
Custer, supra note 24, at 203.
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Less invasive methods would be monitoring the athlete’s deoxyribonucleic acid
(DNA) to detect changes and foreign DNA based on an initial base line DNA test,
looking for the presence of virus vectors, and using imaging to detect artificial genes 39.
These methods, however, are currently impractical and not reliable enough to use for
competition 40. Likely alternatives would be to monitor for indirect evidence of gene
doping such as changing focus to the proteins such genes would produce. While this
method would not catch instances where muscles have been genetically enhanced and
produce no byproduct in the bloodstream, it could be effective at detecting EPO since
abnormal levels of hematocrit would be present in the bloodstream 41.
The current method for detecting EPO in athletes involves a “biological passport”
which keeps track of the athletes hematocrit levels overtime after an initial baseline test
42

. If a suspicious spike is detected, then sporting organizations have grounds to ban an

athlete based on indirect evidence of hematocrit levels 43. This method’s effectiveness
would be limited in the context of gene doping because an athlete who has gene doped
before his or her baseline test would continue to have an artificially high hematocrit level
due to the procedure’s permanency. Similarly, athletes with a natural genetic mutation,
such as Finnish cross-country skier Eero Mantyranta, would be labeled cheats for
naturally producing hematocrit levels beyond the normal threshold 44. Further, athletes

39

Wenner, supra note 29, at 13.
Id.
41
Jurith & Beddoes, supra note 25, at 470.
42
Unal & Unal, supra note 13, at 360.
43
The Future of Cheating: EPO Gene Doping, CYCLING TIPS, (last visited May 14,
2013), http://www.cyclingtips.com.au/2013/02/the-future-of-blood-doping-epo-genedoping/.
44
David T. Martin et al, Blood Testing for Professional Cyclists: What's a Fair
Hematocrit Limit?, SPORTSCIENCE NEWS (last visited May 14, 2013),
40
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with a legitimate baseline test might opt to elevate their hematocrit levels over time, by
modifying their EPO expression incrementally, as to not produce sudden spikes that are
indicative of doping prior to competition. Still, this method is potentially dangerous since
it is purely based on indirect evidence and would vilify athletes such as Eero Mantyranta,
who was born with unusually high hematocrit levels as a result of a natural genetic
mutation 45.

D. Risks, Uncertainties, and Other Considerations
As of now, it is hard to tell what exactly the risks of gene doping are since there
are no known cases of gene doping that have surfaced, and genetic modification has only
been used in a clinical context 46. In 1999, Jesse Gelsinger died shortly after a gene
therapy clinical trial 47. Even though his rare liver disease was not life threatening, the
immune response his body had proved the procedure to be fatal and halted gene therapy
trials in the U.S. for some time after 48.
It is thought that EPO gene doping would carry the same risks as pharmaceutical
EPO, such as circulatory abnormalities that can cause internal bleeding and death 49.
Vascular Endothelial Growth Factor (VEGF) is thought to influence the expression of
more than 200 genes, many of which are not well understood yet and have the potential

http://www.sportsci.org/news/news9703/AISblood.html; Eero Mantyranta, SPORTS
REFERENCE (last visited May 14, 2013), http://www.sportsreference.com/olympics/athletes/ma/eero-mantyranta-1.html.
45
Aschwanden, supra note 17, at 29.
46
Challenges in Gene Therapy, GENETIC SCIENCE LEARNING CENTER (last visited May
14, 2013), http://learn.genetics.utah.edu/content/tech/genetherapy/gtchallenges/.
47
Id.
48
Id.
49
CYCLING TIPS, supra note 43.
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for serious complications 50. Since the rate of expression varies from one individual to
another, genetic modification is still far from a precise science 51. There is a high
probability that if the bloodstream is oversaturated with red blood cells, it would become
too thick for the heart to pump 52.
Just recently, WADA announced that it would hold a meeting in China to review
the progress of developing tests for gene doping, with hopes that they will be available by
the next Olympics 53. Under review are two tests that WADA described as major
breakthroughs: a blood test detecting gene doping as far back as 56 days, and another test
for detecting gene doping in muscles 54. WADA says it has the scientific basis to detect
gene doping, but that the methods would have to be developed in order to make the tests
effective in real-world scenarios 55. This method is crucial as WADA was embarrassed
that Lance Armstrong was able to beat over 500 doping tests in his career 56. The pressure
is also on for WADA because scientists working on potential genetics cures have been
contacted about genetic techniques to enhance performance 57. Without the proper

50

Id.
Hanna, supra note 10.
52
Leslie Johns, 5 Things You Need To Know About Having Too Many Red Blood Cells,
LIVESTRONG (last visited May 14, 2013), http://www.livestrong.com/article/5987-needhaving-many-red-blood/.
53
Stephen Wilson, WADA to Hold Meeting in China on Gene Doping, ABC NEWS (last
visited May 14, 2013), http://abcnews.go.com/Sports/wireStory/wada-hold-meetingchina-gene-doping-19098995#.UZJvXZUo1zs.
54
Id.
55
Id.
56
Brendan Gallagher, Lance Armstrong was Tipped Off 20 Minutes Before he was
Tested, Claims French Anti-Doping Official, THE TELEGRAPH (last visited May 14, 2013),
http://www.telegraph.co.uk/sport/othersports/cycling/lancearmstrong/9499744/LanceArmstrong-was-tipped-off-20-minutes-before-he-was-tested-claims-French-anti-dopingofficial.html.
57
Wilson, supra note 53.
51
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methods of administering potential doping tests, athletes will all too easily think of ways
to beat them.
As mentioned above, somatic gene transfer only affects the athlete's body, yet
germline transfer would affect the human genome, meaning the changes would be passed
on to the offspring 58. Currently, there are no (known) germline clinical trials as its ethical
value and desirability are being debated, however, somatic transfers can inadvertently
lead to germline transfers since the methods of delivery can be hit-or-miss 59. Thus,
genetic therapy is at such an early stage that there are many uncertainties, and the
potential to unbalance genetic expression, alter or mutate the genome, and affect
offspring is very real 60. Perhaps the only certainty is that unscrupulous athletes will forgo
these risks to gain a competitive edge 61.

III.

Legal and Moral Framework of Doping in Athletics
In the past two decades a number of doping scandals have pressured international

doping agencies to become more harmonized and effective at combating performanceenhancing drugs 62. In 1999 the International Olympic Committee (IOC) called on the
International Sports Federations and National Olympic Committees to meet in Lausanne,

58

Hanna, supra note 10.
Id.
60
John Naish, Genetically Modified Athletes: Forget Drugs. There are Even Suggestions
Some Chinese Athletes' Genes are Altered to Make Them Stronger, MAIL ONLINE (last
visited May 14, 2013), http://www.dailymail.co.uk/news/article-2181873/Geneticallymodified-athletes-Forget-drugs-There-suggestions-Chinese-athletes-genes-altered-makestronger.html.
61
Id.
62
ANDY MIAH, GENETICALLY MODIFIED ATHLETES: BIOMEDICAL ETHICS, GENE DOPING
AND SPORT 33 (Routledge, 1st ed. 2004).
59
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Switzerland for the World Conference on Doping in Sport 63. The result was the
establishment of the World Anti Doping Agency (WADA), which was created with two
overriding principles: promoting fair play and protecting athletes’ health 64. As part of its
mission WADA continually updates the World Anti-Doping Code, which lists all banned
PEDs (anabolic steroids, amphetamine, EPO) and methods (blood doping and gene
doping) that athletes are required to abide by 65. Likewise, individual countries have their
own anti-doping bodies, such as the U.S. Anti Doping Agency (USADA), to help
implement and administer WADA’s goals 66.
Within these anti-doping bodies, a discussion over gene doping has ensued for the
past decade, recognizing that it will be confronted in the future 67. While WADA and
others have often been criticized for responding slowly, they took full advantage of this
opportunity to put in place a policy prior to the development of gene-doped athletes 68. As
early as 2001 the IOC formed a group to address the future of gene doping in which they
found that genetic modification could be medically sound, yet should be kept out of
sports 69. The IOC Gene Therapy Working Group concluded,

63

Custer, supra note 34, at 191.
WADA History, WORLD ANTI-DOPING AGENCY (last visited May 14, 2013),
http://www.wada-ama.org/en/About-WADA/History/WADA-History/.
65
World Anti-Doping Code, WORLD ANTI-DOPING AGENCY (last visited May 14, 2013),
http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-DopingOrganizations/The-Code/.
66
About USADA, US ANTI-DOPING AGENCY (last visited May 14, 2013),
http://www.usada.org/about.
67
WADA, Special Feature: Gene Doping, 1 PLAY TRUE at 12, http://www.wadaama.org/Documents/Resources/Publications/PlayTrue_Magazine/PlayTrue_2005_1_Gen
e_Doping_EN.pdf.
68
MIAH, supra note 62, at 38.
69
Id. at 12.
64
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"we are aware there is potential for abuse of gene therapy
medicines and we shall begin to establish procedures and
state-of-the-art testing methods for identifying athletes who
might misuse such technology" 70.

Since then doping investigations have shown how urgent this issue is, revealing evidence
of running coach Thomas Springstein referencing Repoxygen in an email 71. Repoxygen
is a form of EPO used in conjunction with gene therapy for anemic patients and would
increase red blood cell production in enhanced athletes 72.
The next step taken against gene doping was WADA’s Banbury Conference in
which its President, Richard Pound, explained that gene doping would make the realm of
pharmaceutical doping look like the dark ages 73. In his push to speed the development of
an anti gene-doping framework, two ideas emerged. The conference called for a gene
doping detection program backed with numerous grants in the areas of genomics,
proteomics, metabolomics, bioinformatics, and viral detection oriented at researching
detection methods, as well as including gene doping within the World Anti-Doping Code
74

. The addition of an anti gene-doping clause in the Code reflects the majority stance of

anti-doping organizations that genetic modification is to be strictly banned from sports 75.
WADA’s Pound has said that gene doping is a “slippery slope we do not ever want to go
70

International Olympic Committee, Gene Therapy Working Group - Conclusions, IOC
(last visited May 14, 2013), http://www.olympic.org/content/news/mediaresources/manual-news/1999-2009/2001/06/06/ioc-gene-therapy-working-group--conclusions/.
71
Custer, supra note 34, at 20.
72
Id.
73
SCHNEIDER & FRIEDMANN, supra note 12, at 71.
74
Oliver Rabin, WADA Research Program on Gene Doping, WADA, http://www.wadaama.org/rtecontent/document/2008_Stpetersburg_declaration_Dr.rabin.pdf; The World
Anti-Doping Code, supra note 65, at M3.
75
MIAH, supra note 62, at 178.
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down” 76. The labeling of genetic modification as a form of “doping” was a significant
step in banning it, as it makes clear the negative connotation associated with it 77. Pound
has stated that WADA will fight gene doping just as vigorously as pharmaceutical doping
since he and his colleges believe sports will not benefit from gene doped athletes, and it
is critical to prevent such practices before they become widespread 78.
WADA’s justifications for banning genetic modification from sports are currently
legitimate, as clinical studies have shown to have deadly side effects 79. Further, since
genetic doping is a permanent modification of the body there is a danger that if the
foreign gene produces too much of its protein product, there is no way to reduce or stop it
80

. Another concern is that the interaction of the foreign gene with the native genes might

have an unbalancing effect on the body resulting in a condition called pleiotropy, in
which the foreign gene that was intended to boost EPO might accidently effect a
completely unrelated gene and cause damage to the body 81. Finally, gene doping that
targets specific muscles, such as IGF-1, would only strengthen the targeted muscles
without strengthening their adjoining tendons and ligaments, putting the athlete at risk of
injury every time he or she uses that muscle and puts strain on its connective tissue 82.

76

WADA, supra note 67, at 1.
Custer, supra note 34, at 197.
78
MIAH, supra note 62, at 54.
79
SCHNEIDER & FRIEDMANN, supra note 12, at 29-30.
80
Aschwaden, supra note 17.
81
Randall Mayes, The Modern Olympics & Post-Modern Athletics: A Clash in Values,
THE JOURNAL OF PHILOSOPHY, SCIENCE & LAW (last visited May 14, 2013),
http://www6.miami.edu/ethics/jpsl/archives/all/Olympics%20and%20Athletics.html.
82
PRESIDENT’S COUNCIL ON BIOETHICS, BEYOND THERAPY: BIOTECHNOLOGY AND THE
PURSUIT OF HAPPINESS 112 (2003), available at
http://changethis.com/manifesto/9.BeyondTherapy/pdf/9.BeyondTherapy.pdf.
77
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Due to the concern of the side effects above many associations in the U.S. such as
the Recombinant DNA Advisory Committee (RAC) will not approve genetic
modification aimed at anything but treatment 83. Countries around the world, such as the
United States, have enacted strict requirements for genetic clinical studies, requiring
approval from the U.S. Food and Drug Administration (FDA), National Institutes of
Health (NIH), and the RAC before any federal funds are allocated 84.
These steps, however, might not be enough, as athletes would seek laboratories
operating illegally in and outside of the US 85. The possibility that athletes would turn to
the black market if gene doping were banned is a very real one as history has shown this
to be the case with other illicit substances such as drugs and alcohol 86. The
counterargument would be to legalize genetic modification so that it is regulated, leaving
the athlete to decide whether the pros outweigh the cons 87.
While athletes engage in risk analysis every time they compete, perhaps the
consequences of gene doping are currently too unknown for the athlete to make a
reasoned decision. Likewise, WADA's national affiliates such as the United Kingdom
Anti-Doping Authority (UKAD) and USADA have echoed WADA's stance and
introduced campaigns such as "100% me" backed by multi-gold medalist Sir Chris Hoy,
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and have relentlessly taken down doping "king pins" such as Lance Armstrong in the last
year 88.
An additional concern over gene doping would be that its unknown risk/benefit
analysis would make it impossible for athletes to give informed consent, undermining the
most basic tenet of medical practice 89. Athletes would likely not appreciate the unknown
risks when weighed against the money and pride associated with winning. This concept is
known as the Goldman Dilemma, in which elite athletes were asked on a biannual basis
since the 1980s whether they would take a drug guarantying them Olympic gold if it
would also kill them within five years 90. Over half of the athletes said yes each time the
survey was conducted 91. Similarly, other athletes would feel pressured to make the jump
and gene dope, as not doing so would put their livelihood at risk 92. Many elite athletes,
particularly from underdeveloped countries, would be faced with the decision to dope and
remain competitive or work in the mines back home. They justify doping as a way to
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even the playing field, and that they are not necessarily cheating since they do not have
an advantage over their competition 93.
WADA has taken it upon itself to educate athletes, trainers and physicians of the
dangers of gene doping, specifically in its St. Petersburg Declaration 94. One of their
conclusions was that athletes, trainers, and physicians should be educated so that they can
critically assess claims on the Internet or elsewhere about the benefits (and detriments) of
gene doping 95. Their stance reflects the current unknown consequences of gene doping
and the impossibility of obtaining informed consent without better knowing the
associated risks 96. Yet, there is a possibility that after adequate testing gene doping could
be safe and/or the risk would be quantifiable. Arguably, this would undermine WADA’s
primary justification of the athlete’s safety and shift the argument to fair play 97.
In all, the IOC, WADA, USADA, UKAD, and other organizations under this
umbrella share the same policy stance about genetics; that gene therapy is a promising
technology that can be abused by athletes as a form of doping 98. While there are no gene
doping tests currently in practice, the mentioned organizations have been working
steadfastly to come up with one by the next Olympics 99. That being said, there has been
speculation over certain Chinese swimmers who performed way beyond their previous
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results at London 2012, as well as reports of Chinese hospitals offering gene therapies to
anyone willing to pay their price, but until a test is developed this can only be speculation
100

. Still, the increase in media coverage on the topic has shown just how imminent gene

doping is.

IV.

How Should WADA Regulate Gene Doping?
As mentioned in the introduction, it is unclear whether gene doping should be

treated like pharmaceutical doping or as a technological innovation. Even if gene doping
is treated like anabolic steroid use and is completely banned, there would be problems in
applying the black and white approach of doping sanctions in the gray area of gene
modification. For one, the permanency of gene modification would impose a lifelong ban
on an athlete, running at odds with WADA's constitutional approach of granting second
chances 101. While there are many similarities between traditional pharmaceutical doping
and gene doping, there are just as many similarities between gene doping and non-genetic
technological innovation in sport. Cyclists benefit from the latest aerodynamic equipment
to help them reduce drag, ski-jumpers benefit from the latest skin suits to help them hold
flight in the air, swimmers benefitted from slippery swimsuits, and disabled runners
benefit from the latest prosthetic legs so much so that their competitors claim the
prosthetics are faster than real legs 102.
The primary difference between pharmaceutical doping and gene doping is that in
gene doping genetic material is introduced and assimilated into the body where as in
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traditional forms of doping, the substance stimulates growth in the body and the
development of new cells temporarily. The distinction is that pharmaceutical doping
actively stimulates change in the body that is excreted for a limited time, where as genetic
material has to be assimilated by the body, which then expresses the desired changes,
based on the new genetic code going forward. While this may seem to be a very narrow
distinction, it might make all the difference when one compares gene doping to high
altitude training.
In altitude training the lack of oxygen in the air forces the body to adapt and
produce more red blood cells so that it becomes more efficient at absorbing the scarce
oxygen 103. Further, there are altitude chambers readily available for purchase that allow
athletes to reduce the density of air while they sleep at night, without ever having to step
foot on a mountain 104. In 2006, WADA decided not to ban altitude chambers because
their biological response came only as a result of informational input (i.e. lower oxygen
content) instead of a pharmaceutical reaction 105. Thus, the similarity between gene
doping and altitude training is that the input forces the body to adapt and modify its
output, which is distinguishable from pharmaceutical doping, which artificially trumps
the DNA and stimulates the body to produce more output without a biological response
106

.
Commentators such as Coleman have pointed out that while steroids push the

body to grow more and produce more tissue, genetic material “cannot cause the body to
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be more and perform differently that its genes would otherwise allow” 107. In essence, the
performance benefits of gene doping are the products of the athlete’s own body, albeit
enhanced. Yet, Coleman’s conclusions raise questions on what constitutes a person’s
DNA, particularly when a genetic transfer becomes the athletes own permanent DNA.
Does a person who undergoes gene therapy ever get to claim ownership of their DNA, or
do they forever carry the stigma (i.e. plastic surgery, Botox, silicone implants) of being
genetically enhanced? In the context of genetic transfer, perhaps sporting bodies would
debate whether only the athlete’s DNA at birth is his or her own DNA, despite the
permanency genetic transfer would have on the athlete’s actual DNA. This debate could
go either way, indicating that current anti-doping measures would be inadequate at
dealing with genetic doping since it raises too many questions and too closely resembles
natural adaptations.
If and when gene doping becomes widespread, doping authorities will be faced
with many challenges such as the difficulty of detection through blood work or the overly
expensive and intrusive nature of muscle biopsy. Yet, if authorities develop an
inexpensive, unobtrusive, and effective means of catching gene dopers, they would still
run into difficulty distinguishing between cheaters and those like Finnish skier Eero
Mantyranta who was born with a genetic mutation 108.
Once genetic material is introduced to the body, there is no way of removing or
muting that material, meaning that the change is permanent. The dilemma is that such a
genetically modified athlete would have to be banned for life since they would always be
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genetically enhanced 109. While the risk of a lifetime ban is the athlete’s, this one-anddone ban runs against WADA’s policies, which allow for athletes to come clean and have
a second chance 110. WADA’s policy explicitly mandates a two-year suspension for first
time offenders, yet under their current zero-tolerance policy, the two-year suspension
would last indefinitely since genetic change is permanent 111.
WADA's constitutional conflict would mean that even an athlete who admits to
having done wrong by gene doping could not be given a second chance since that athlete
will forever be genetic enhanced! Currently, a number of reformed cyclists are serving as
anti-doping ambassadors in the sport; a fair tradeoff for athletes deserving a second
chance 112. Yet, without having such an opportunity, gene dopers would be quickly
forgotten and their competitors would just as quickly forget about the consequences of
gene doping. This disparate treatment would be even more pronounced if two athletes
were caught for using EPO, one pharmaceutical and the other genetic. After two years,
the pharmaceutical doper would be cleared to compete, but the genetic doper cannot since
it is known that his condition is permanent. Perhaps the only way for the gene doper to
compete again would be to undergo a reversing treatment (if one were possible) and then
be tested for reinstatement.
Moreover, athletes, just like all other people should have access to therapeutic
gene uses (as opposed to enhancements) when they become medically available 113.
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WADA’s Code provides for “therapeutic use exemptions” when treatment requires the
legitimate use of drugs not permitted in competition 114. Under traditional therapeutic
treatment, athletes can return to competition free of any sanctions once the procedure is
completed 115. The moral dilemma comes up when at an early age a child undergoes
therapeutic gene modification and later wishes to compete at the elite level 116. Does
WADA then ban the athlete for having a necessary procedure, or recognize its legitimacy
and allow the athlete to compete with a distinct advantage 117? Further, what if a famous
athlete is diagnosed with cancer and the only means of treatment is genetic modification
using EPO. Would sporting bodies make an exception to allow the athlete to compete,
and would competitors feel such an exception was fair?
Bans on genetic modification could run opposed to human rights standards under
the Universal Declaration on the Human Genome and Human Rights 118. Article 2 states
that “everyone has a right to respect for their dignity and for their rights regardless of
their genetic characteristics,” and Article 6 states “no one shall be subjected to
discrimination based on genetic characteristics that are intended to infringe or have the
effect of infringing human rights” 119. Indeed, this would be a difficult decision for
WADA to make because neither of the two outcomes, banning the athlete or letting the
athlete complete, would be fair. Hence, the anti-doping authorities need to rethink their
policies and provide for an alternative means of dealing with genetically modified
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athletes, particularly when such athletes had no malicious intent to cheat. I suggest, that
WADA regulate enhanced athletes by enforcing a measurable handicap appropriate for
their sport, or putting enhanced athletes in a separate, enhanced category of competition.
Obviously, WADA has already passed judgment on genetic modification by
labeling it “gene doping” and tried to take a stance on the practice before it becomes
prevalent 120. Yet, genetic modification shows promise in the many legitimate benefits it
could provide to society 121. If the medical field and society at large perceive genetic
modification in the eyes of WADA, perhaps the technology would never realize its full
potential 122.
The first step WADA should take is relabeling “gene doping” into a more neutral
title to remove the negative connotation it receives by being called “doping.” The Code
can continue to disallow it for now, since the point would be to allow society to make up
their minds on whether genetic modification is good or bad, without being told by
WADA and USADA that genetic modification is the equivalent of pharmaceutical
doping. WADA itself recognized the impact it has on social perceptions in its St.
Petersburg Declaration, noting that sport is likely one of the first places where genetic
treatment and enhancement will be debated 123.
Under the current regime, steroid use is the equivalent to illicit drug use and by
and large society has taken the stance that illicit drug use is unacceptable 124. Entire
campaigns are focused around dissuading people from taking drugs, not leaving it up to
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the individual to decide whether or not drugs are good or bad 125. If genetic modification
were also grouped into this category as a result of WADA’s policies, perhaps society
would dismiss the potential benefits of gene therapy as a deviant practice without even
giving it a chance 126. If genetic modification is given a chance and is found to be
beneficial to society, WADA’s dismissive stance on the subject would pigeonhole it from
what society has decided is acceptable 127.
If and when society decides that genetic modification is acceptable, authorities
need to decide where to redraw the line. Allowing all forms of genetic modification
cannot be the solution as the financial and social benefits association with winning a
competition would pressure all athletes to genetically enhance just to remain competitive.
WADA and other sporting authorities would have to maintain some level of fairness in
order to keep both natural and enhanced athletes content. If athletes were completely free
to gene dope, sport would turn into an arms race of who can purchase better genes,
making the cost of competition prohibitive to less established athletes.
One option would be to disregard how an athlete with abnormal levels of
hematocrit obtained them (whether it be through pharmaceutical EPO, genetic EPO, or
genetic mutation) and say that cyclist, runners, and other endurance athletes with more
than “x” amount of “y” cannot participate in the same category deemed to be natural.
This could then go in anyone of two ways: either such athletes would have no category to
compete in, or such athletes would compete in an enhanced category. The name of the
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enhanced category can be strategic in order to dissuade athletes from the "gene doped"
category and incentivize remaining clean for the natural category.
Another option would be to single out the athletes with abnormal levels of EPO or
IGF-1 and conduct an investigation on whether such elevated levels are products of
legitimate therapeutic uses or illegitimate attempts at cheating. At that point athletes
without a legitimate therapeutic use (i.e. they were dying of cancer) would be banned
from competition so long as such levels remain abnormally high. This, however, would
inevitably come to the question of which therapeutic uses are legitimate. Cancer certainly
would be one, but perhaps other procedures would be mere charades for dopers. While
this investigatory method would be harsh to athletes like Eero Mantyranta, perhaps the
level playing field for all others would make up for it. On that note, if the Mantyrantas of
the world wanted to compete, they might (emphasis on might) be able to genetically
diminish their EPO levels.
A final option would be allow those athletes to compete side by side natural
athletes, but to attach some quantifiable “handicap” to their performance such as having
them run 27 mile marathons (instead of 26.2) or having them sprint 110 meters (instead
of 100). The difficulty here would be coming up with what handicap would exactly
compensate for a gene doper's genetic advantage. Racer are won or lost by hundredths of
a second, and thus, every inch would matter.
While quantifiable handicaps might not translate well in all sports, it is at least
another available option to deal with genetic modification. In fact, many amateur level
cycling races make use of racing handicaps to deal with varying levels of skill and
experience. For example, in order for a race promoter to break even, the promoter might
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allow Cat.3 (low category) cyclist to compete with Pro, Cat.1 (high), and Cat.2
(intermediate) cyclist. While the Cat.3’s would be at a distinct disadvantage, the promoter
might attempt to level the playing field by starting the Cat.3’s with a two-minute
advantage 128. Similarly, other sports such as boxing, wrestling, and rowing have weight
categories to accommodate athletes that cannot compete against competition with a
distinct (but natural) size advantage 129. Finally, athletic competition is already divided
among lines of gender because it is believed that intermingling competition would be
unfair to one or both genders 130. Yet, there are instances where female athletes that
outperform their competition are allowed to compete against males 131. In rowing, female
coxswains are free to compete in both male and female events since it is their
nonphysical skills (motivating rowers and steering the boat) that set them apart. Still,
instances of males competing in female sports are nearly unheard of, save a few
transgender cases 132.
These alternative methods do of course have some limitations. For example,
creating distinct categories for enhanced athletes might not be as easy as it sounds since it
would require sporting bodies to handle the logistics of another race, game, league and so
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on. Creating a separate category might be a financial nightmare particularly if it
consumes a lot of the promoter’s time for only a few athletes that compete at the
enhanced level. Further, if athletes find the enhanced level to be more lucrative than their
present level, this might unnecessarily pressure them into genetic enhancement. The other
side of this argument is that if there is no league for enhanced athletes, they have
nowhere to compete and could be faced with the decision to forgo necessary genetic
treatment in order to compete.
Another limitation would be how to effectively categorize the athletes. To say that
the only relevant trait in cycling is your hematocrit level would be to severely undermine
all other factors such as training, motivation, and skill. Similarly, to say that IGF-1 is the
only relevant factor in weightlifting would be to eliminate all other means that athletes
could use to cheat. If sporting bodies only tested EPO or IGF-1 then athletes would look
for other means to avoid the enhanced category. Ultimately, if sporting bodies were
concerned for their athletes’ health, they would find a way to allow for genetic
modification in a controlled manner because its outright ban simply forces people to the
black market.
On the other hand, sports could play a vital role in developing genetic therapies,
as the medical field might race to catch a portion of the market share. For example, Dr.
Dello Russo is one of a handful of doctors that pioneered lasik surgery in the 1990s, and
has local professional teams such as the NY Giants and Brooklyn Nets endorse his
procedure 133. The public, at large, recognizes that a football and basketball player’s
vision is crucial to his or her success and would think that if such athlete used the
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procedure then they would try it too. As a result, Dr. Dello Russo is known as the leading
lasik surgeon in the area, if not the country, and has captured a large portion of the
market for lasik 134.
Traditionalists would likely argue that allowing any form of genetic modification
in sports would defeat the romantic ideal of sport as the spirit’s triumph over body and
result in competition that is so unreal that sports would become a spectacle 135.
Friedmann explains,

“what are the endpoints of manipulation?.. How fully can
we engineer the human body… something that looks like a
human, but is so engineered, that it’s no longer going to do
what the body is designed to do” 136?

Others would argue that the very nature of sport is incrementally getting stronger, better,
faster. Currently, it's clear what field WADA stands in, yet, this traditionalist approach
does not necessarily reflect society’s stance since it has not yet had a chance to judge 137.
Ideally, WADA will find a way to balance its priorities of fair play and athletes' health
with the game changing reality that genetic modification will be.

V.

Conclusion
At this point in the debate, it is hard to say which method of dealing with gene

doping is best, or that certain options are superior to others as all have their own pros and
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cons. The point is simply to open the discussion and have athletes, sporting bodies, and
society at large take a clean look at “gene doping” and decide how they want to proceed.
Personally, I believe that if genetic modification develops into a legitimate
practice, then sporting bodies should not interfere by smudging it as "doping" for the sake
of maintaining their integrity. WADA has the opportunity to play an instrumental role in
the development of genetic modification by neutralizing its stance on “gene doping” and
collaborating with the scientific and medical communities to monitor the development of
genetic therapies. By labeling genetic modification "gene doping" it has already burnt
bridges in a potential enterprise to enrich both everyday people and elite athletes.
Further, I feel strongly against prohibiting athletes from competing for whatever
reason, whether they doped or were treated for disease via genetic transfer. Thus, I feel
that sporting organization should accommodate all athletes by finding a fair way for them
to compete either in separate enhanced leagues, or natural leagues with a handicap. I
believe strongly in dissuading athletes from cheating, yet I feel equally as strong about
giving repentant athletes a second chance.
Finally, WADA’s role will inevitably shape the public’s view of how such gene
therapies are perceived, and so they will have to be particularly careful of where to draw
the line in order to not discourage the development of genetic therapies while also
preserving the integrity of their organization and sport as a whole. The future leaves us
with many Superbowls, Tours de France, and Olympics ahead, and one can only wait to
see how genetic modification is received.

